ORKA-001: a novel half-life extended IL-23p19 monoclonal antibody Oruka plans to initiate a Phase 1 trial of ORKA-001 in the ...
and IL-17F/F dimers. Its smaller size as a Nanobody ® compared to antibodies allows it to better penetrate and treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback